The growth
of aseptic sampling market is driven majorly by the increasing demand for
biopharmaceuticals, stringent government regulations to ensure drug safety, and
funding to support life sciences research activities. On the other hand, issues
related to leachables and extractables from single-use products is restraining
market growth.
Aseptic Sampling Market Dynamics: Impact Analysis
1. Increased risk of pandemics and communicable diseases
2. Emerging markets to offer lucrative growth opportunities
3. Funding to support life science research activities
The global aseptic sampling market is projected to reach USD 474 million by 2025 from USD 264
million in 2020, at a CAGR of 12.4%.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global Aseptic
Sampling market?
2. What are the drivers, restraints, opportunities, and challenges in the
Aseptic Sampling Industry?
3. What are the opportunities
for stakeholders and provide details of the competitive landscape for key
players?
4. What will be growth of Aseptic Sampling in North America, Europe, Asia
Pacific, Latin America, and the Middle East and Africa?
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9034729
Biotechnology and Pharmaceutical Segment:
Based
on end user, the aseptic sampling market is segmented into biotechnology and
pharmaceutical manufacturers, contract research and manufacturing
organizations, R&D departments, and other end users. In 2019, biotechnology
and pharmaceutical manufacturers segment dominated this market owing to the
increasing adoption of aseptic sampling in existing manufacturing facilities
owing to advantages such as low capital cost and easy implementation.
Asia Pacific Region to Dominate The Market:
The
Asia Pacific is expected to grow at the highest rate in the aseptic sampling
market. The major factors driving the growth of this market include the
expanding biomanufacturing sector, increasing government support, developing
R&D infrastructure, and the growing outsourcing of bioproduction processes
to this region from North America and Europe.
Key Players:
The prominent players in the aseptic sampling market include
Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher
Corporation (US), and Thermo Fisher Scientific (US), Saint-Gobain (France), GEA
Group (Germany), Avantor, Inc. (US), QualiTru Sampling Systems (US), Keofitt
(Denmark), GEMÜ Group (US), W. L. Gore & Associates (US), Flownamics
Analytical Instruments, Inc. (US), Lonza (Switzerland), and Trace Analytics
(US). Major players have focused on expansion, agreements, and partnerships to
increase their shares in the global aseptic sampling market.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=9034729
Merck is one of the leading players in the aseptic sampling market. The
company’s leading position can be attributed to its extensive portfolio of
aseptic sampling and a strong geographical footprint. The company focuses on
the high-growth Asia region to increase its market share and revenue. In the
last three years, the company opened life science centers in China, India,
South Korea, and Singapore, in order to facilitate the supply of its products
in the region. Such developments help in expanding Merck’s presence in the
aseptic sampling market, thus maintaining its leading position.
